Funder
Macular Disease Foundation Australia (MDFA). There is no grant reference number.
Macular Disease Foundation Australia
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta- analysis. Lancet. 2014;2:106–16.
2. Department of Health. PBS Expenditure and Prescriptions Report 1 July 2019 to 30 June 2020. (PBS Information Management Section, Canberra, ACT, 2020.
3. Chatziralli I, Mitropoulos P, Parikakis E, Niakis D, Labiris G. Risk factors for poor quality of life among patients with age-related macular degeneration. Semin Ophthalmol. 2017;32:772–80.
4. Inan S, Cetinkaya E, Duman R, Dogan I, Inan UU. Quality of life among patients with age-related severe macular degeneration assessed using the NEI-VFQ, HADS-A, HADS-D and SF-36 tests. A cross-sectional study. Sao Paulo Med J. 2019;137:25–32.
5. Senra H, Balaskas K, Mahmoodi N, Aslam T. Experience of Anti-VEGF treatment and clinical levels of depression and anxiety in patients with wet age-related macular degeneration. Am J Ophthalmol. 2017;177:213–24.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献